Forbes Institute for Cancer Discovery
The end of cancer begins here
The institute encourages scientists across the university to undertake high-risk, high-reward initiatives with the potential to drive new advances in cancer research. The intent is to fuel rapid development of innovative technology and new therapies, bringing better, more targeted treatments to the 1.6 million Americans diagnosed with cancer each year.
The Forbes Institute continues a hallmark of the Rogel Cancer Center by fostering collaboration across the university. Rogel Cancer Cennter members come from 48 university departments across nine schools, demonstrating a breadth of interdisciplinary collaboration not seen elsewhere.
The Forbes Scholars program provides grants to senior investigators as well as to junior faculty. Team science awards will encourage innovative discovery by multidisciplinary teams.
The institute will also facilitate the development of new technologies such as single cell genomics, which will hasten cancer drug development and personalized oncology.
Help support the Forbes Institute and its mission. Make a gift today.